Reviv3 Procare Company
RVIV · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $0 | $0 | $0 |
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | – | – | – | 100% |
| EBITDA | $0 | – | $0 | $0 |
| % Margin | – | – | – | 12.2% |
| Net Income | $0 | – | $0 | $0 |
| % Margin | – | – | – | 11.5% |
| EPS Diluted | 0 | – | 0.07 | 0.059 |
| % Growth | – | – | 19% | – |
| Operating Cash Flow | – | – | -$0 | – |
| Capital Expenditures | – | – | -$0 | – |
| Free Cash Flow | – | – | -$0 | – |